NEW
YORK, March 29, 2024 /PRNewswire/
-- The Kinetix Group (TKG) and Pfizer
Inflammation and Immunology received a PM360 Pharma
Choice Award for their recent health equity initiative. The
award recognized Pfizer's atopic dermatitis interactive guide for
varying skin tones.
The Pfizer Inflammation and Immunology Strategic Customer Group
originally developed the idea to address a gap in equitable patient
and provider education resources surrounding atopic dermatitis. The
team partnered with TKG to drive awareness for patients with skin
of color.
"I am proud to be a part of a company like TKG, where there is a
genuine commitment to addressing health equity and social
determinants of health. TKG not only cares about these issues but
actively collaborates with others in the industry who share the
same dedication to making a difference for patients. Being
recognized for my contribution is a significant accomplishment, and
it is encouraging to see a growing awareness and concern for these
critical issues," said Haley Toomer,
manager and member of the winning team.
As an industry-voted award, the Pharma Choice
Awards celebrate the greatest healthcare and life science
creatives, chosen by those who know the industry best. Viewers can
vote for their favorite entries in 14 categories including
Direct-To-Consumer/Direct-To-Patient, Multichannel, Multicultural,
Unbranded and more.
"At TKG, we wake up every day driven to find novel ways to speed
patient access to lifesaving medication," said Sarah McNulty, president of TKG. "Our business
charter involves meeting patients where they are to holistically
address their needs. This PM360 award is particularly meaningful
because it celebrates the inclusive work that we partner with
clients to deliver and our company culture, which values diversity
and inclusivity."
For more information about the award, visit here or
contact inquiries@thekinetixgroup.com.
The Kinetix Group (TKG)
The Kinetix Group, a healthcare strategic advisory and marketing
agency, is a part of Petauri. TKG empowers life science companies
to effectively engage with health system and payer customers. With
market access expertise, deep relationships, and connections that
span the healthcare ecosystem, TKG is uniquely positioned to
understand its clients' customers and design impactful solutions.
Its core areas of focus are organized customers, market access, and
real-world evidence. To learn more, visit
www.thekinetixgroup.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-kinetix-group-and-pfizer-health-equity-work-recognized-by-pm360-302103544.html
SOURCE The Kinetix Group